Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children

Exhaled nitric oxide (ENO) has been proposed as a marker of airway inflammation in asthma and could be useful to evaluate the response to anti-inflammatory treatment. We investigated the effect of budesonide and nedocromil sodium on ENO levels and lung function in asthmatic children. Twenty stable s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Respiratory medicine 2001-09, Vol.95 (9), p.734-739
Hauptverfasser:	Carrà, S., Gagliardi, L., Zanconato, S., Scollo, M., Azzolin, N., Zacchello, F., Baraldi, E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Analysis of Variance Anti-Asthmatic Agents - therapeutic use Asthma - drug therapy Asthma - metabolism asthma, budesonide, nedocromil sodium, exhaled nitric oxide, children Biological and medical sciences Biomarkers - analysis Breath Tests Budesonide - therapeutic use Child Child, Preschool Cross-Over Studies Female Forced Expiratory Volume - drug effects Humans Luminescent Measurements Male Maximal Midexpiratory Flow Rate - drug effects Medical sciences Nedocromil - therapeutic use Nitric Oxide - analysis Pharmacology. Drug treatments Respiratory system Single-Blind Method
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!